Programmatic and clinical management of drug resistant tuberculosis in order to achieve sustainable development goals
9-days comprehensive post-graduated course for clinicians is designed combining the latest up-to-date policy framework, guidance and evidence in clinical and programmatic management of DR-TB with intensive practical work of the participants– interactive case studies, group discussions and presentations. Most of courses take place in WHO CC Latvia facilities, located at the TB and Lung Diseases Centre of Riga East University hospital with field visits to MDR-TB department, National TB Reference Laboratory and TB Outpatient department, including collaboration with other social/health/NGO sectors in providing care for the patients. WHO CC Latvia regularly involves regional experts from the field in provision of the course. WHO CC Latvia ensures full logistic support to participants - including accommodation, local transfers, meals and visa invitation.
- Global epidemiology of TB, DR-TB, TB/HIV and WHO strategy and targets for TB prevention, care, and control.
- Updates on diagnosis of TB and DR-TB and TB diagnostic algorithm proposed by the European TB Laboratory Initiative.
- Clinical aspects of case detection of DR-TB.
- Use of shorter DR-TB regimens in European regions. New guidelines for treatment of RR-TB. Treatment regimen design for DR-TB.
diagnosis and treatment for HIV co-infected patients. Possible drug-drug
interactions between antiretrovirals and
the new TB drugs.
- Diagnosis and treatment of latent TB infection.
- Management of TB in children. Management of DR-TB in special situations. Adjuvant therapies in DR-TB management.
- Monitoring of DR-TB treatment effectiveness.
Active drug safety monitoring and management (aDSM).
- Fundamentals of infection control; FAST: a TB infection control strategy.
- Contact finding and investigation.
- Organisation of
TB ambulatory treatment. DR-TB case management ambulatory, including patient
adherence and collaboration with local NGO`s, social and other healtcare
- Developing models of care for DR-TB patients; people-centered TB care.
- Health communication for health care workers working with TB.
- Management of failures and chronic patients.
- Intersectoral collaboration on ending TB, HIV and Hepatitis C in countries.
Site visits to MDR-TB department, National TB Reference Laboratory and TB Outpatient department
Duration and language:
9 business days (from Monday to Wednesday, including Saturday)
Available in Russian and English
Target audience: clinicians, staff of national TB programs, persons responsible for diagnostics and treatment of DR-TB, from countries with high levels of DR-TB
1700 EUR, including training materials, site visit, local transport, catering during working hours/on working days
hotel accommodation (from ~ 40 EUR to ~ 80 EUR per night), international flight, visa, reduced per diem